The Patent Finder

Anabasis S.R.L.

Also on record
Records under this name other than patents Anabasis S.R.L. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Anabasis S.R.L.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,345,749Method of treating intraoccular tissue pathologies with nerve growth factor
Formerly held
Term ended
Ended no later than Jan 21, 2020 · USPTO record
Term endedEnded no later than Jan 21, 2020USPTO record
US 9,468,665Method of treating intraoccular tissue pathologies with nerve growth factor
Formerly held
Term ended
Term ended Jan 21, 2020 · USPTO record
Term endedTerm ended Jan 21, 2020USPTO record
US 7,429,483Use of nerve growth factor for the storage, culture or treatment of cornea
Formerly held
Term ended
Term ended Jan 13, 2020 · USPTO record
Term endedTerm ended Jan 13, 2020USPTO record
US 6,537,808Use of nerve growth factor for the storage, culture or treatment of cornea
Formerly held
Term ended
Term ended Oct 25, 2019 · USPTO record
Term endedTerm ended Oct 25, 2019USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited